Atlas Trials

To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)

Clinical trial NCT03644186 · COMPLETED

Trial details

NCT number
NCT03644186
Sponsor
ETOP IBCSG Partners Foundation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
Start date
2019-04-16
Primary completion
2023-01-03
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.